10-Q

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the quarterly period ended March 31, 2021

☐ Transition Report Under Section 13 or 15(d) of the Securities Exchange Act of 1934

For the transition period from __________ to __________

Commission File Number: 333-174194

GRAPHENE & SOLAR TECHNOLOGIES LTD

(Exact name of registrant as specified in its charter)

colorado	27-2888719
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)

23 Corporate Plaza Drive, Suite 150

Newport Beach, CA 92660

(Address of principal executive offices, including Zip Code)

(949) 432-7525

(Issuer’s telephone number, including area code)

(formally known as Solar Quartz Technologies Corporation)

(Former name or former address if changed since last report)

Check whether the issuer (1) filed all reports required to be filed by section 13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☐ No ☒

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a small reporting company. See the definitions of “large accelerated filer,” “accelerated filer,” “non-accelerated filer,” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated Filer	☐	Accelerated Filer	☐
Non-accelerated Filer	☐	Smaller reporting company	☒
		Emerging growth company	☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

As of May 26, 2021, the registrant had 255,037,319 outstanding shares of common stock.

GRAPHENE & SOLAR TECHNOLOGIES LIMITED

FORM 10-Q

TABLE OF CONTENTS

PART I — FINANCIAL INFORMATION
Item 1.	Condensed Consolidated Balance Sheets (Unaudited)	3
Item 2.	Condensed Consolidated Statements of Operations (Unaudited)	4
Item 3.	Condensed Consolidated Statements of Changes in Stockholders’ Deficiency (Unaudited)	5
Item 4.	Condensed Consolidated Statements of Cash Flows (Unaudited)	6
Item 5.	Management’s Discussion and Analysis of Financial Condition and Results of Operations.	12
Item 6.	Controls and Procedures.	14
PART II — OTHER INFORMATION		16
Item 1	Legal Proceedings	16
Item 1A	Risk Factors	16
Item 2	Unregistered Sales of Equity Securities and Use of Proceeds	16
Item 3	Defaults on Senior Securities	16
Item 4	Mine Safety Disclosures	16
Item 5	Other Information	16
Item 6.	Exhibits.	16
SIGNATURES		17

2

GRAPHENE & SOLAR TECHNOLOGIES LIMITED 

CONDENSED CONSOLIDATED BALANCE SHEETS

	March 31,			September 30,
	2021 (Unaudited)			2020
Assets
Current Assets:
Cash	$	147		$	12
Prepaid expenses		15,723			—
Total Current Assets		15,870			12
Other Assets:
Furniture & Equipment, net of depreciation, $8,986 and $71,803		4,021			12,259
Total Other Assets		4,021			12,259
Total Assets	$	19,891		$	12,271
Liabilities and Stockholders’ Deficit
Current Liabilities:
Accounts payable and other payable	$	785,433		$	653,476
Accrued interest payable		146,702			132,099
Notes payable-in default		60,000			60,000
Due to related parties		810,116			717,075
Convertible notes payable-, net of discount $86,381and $52,703 in default		202,292			116,264
Other loans		5,781			5,632
Total Current Liabilities		2,010,324			1,684,546
Total Liabilities	$	2,010,324		$	1,684,546
Stockholders’ Deficit:
Preferred stock, $0.00001 par value; 10,000,000 shares authorized; none, issued or outstanding
Common stock, $0.00001 par value; 500,000,000 and 500,000,000 shares authorized; 254,487,319 and 246,248,723 shares issued and outstanding		2,546			2,463
Additional paid-in capital		13,495,049			9,508,943
Accumulated other comprehensive income		(15,310	)		52,015
Accumulated deficit		(15,472,718	)		(11,235,696	)
Total stockholders’ deficit		(1,990,433	)		(1,672,275	)
Total liabilities and stockholders’ deficit	$	19,891		$	12,271

The accompanying notes are an integral part of these consolidated financial statements.

3

GRAPHENE & SOLAR TECHNOLOGIES Limited

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND OTHER COMPREHENSIVE INCOME

(Unaudited)

	Three Months Ending March 31						Six Months Ending March 31,
	2021			2020			2021			2020
Revenues	$	—		$	—		$	—		$	—
Costs and expenses
Professional Services		3,545,803			134,237			4,130,354			313,724
General and administrative		38,801			29,559			81,350			85,410
Total costs and expenses		3,584,604			163,796			4,211,704			399,134
Loss from operations		(3,584,604	)		(163,796	)		(4,211,704	)		(399,134	)
Other income (expense) Other income		2,318			1,975			4,509			4,025
Interest expense		(15,551	)		(15,079	)		(29,827	)		(22,445	)
Total other income (expense)		(13,233	)		(13,104	)		(25,318	)		(18,420	)
Net Income (Loss)	$	(3,597,837	)	$	(176,900	)	$	(4,237,022	)	$	(417,554	)
Comprehensive income (Loss)	$	15,312		$	76,505		$	(67,325	)	$	55,404
Net Comprehensive Income (Loss)	$	(3,582,525	)	$	(100,395	)	$	(4,304,347	)	$	(362,150	)
Income (Loss) per share:
Basic and diluted	$	(0.01	)	$	(0.00	)	$	(0.02	)	$	(0.00	)
Weighted average shares outstanding		253,168,937			242,953,034			251,406,796			242,626,956

The accompanying notes are an integral part of these consolidated financial statements.

4

GRAPHENE & SOLAR TECHNOLOGIES LIMITED

(Formerly Solar Quartz Technologies Corporation)

AND SUBSIDIARY

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ DEFICIENCY

(Unaudited)

Three and Six Months Ended March 31, 2021 and 2020

							Accumulated
	Common Stock				Additional		Other						Total
			Par		Paid-in		Comprehensive			Accumulated			Stockholders’
	Shares		Value		Capital		Income			Deficit			Deficiency
Balance, September 30, 2020		246,248,723		2,463		9,508,943		52,015			(11,235,696	)		(1,672,275	)
Shares issued in connection with the sale of common stock		1,450,000		15		84,723		—			—			84,738
Stock-based compensation expense		3,100,000		31		404,969		—			—			405,000
Foreign currency translation adjustment		—		—		—		(82,637	)		—			(82,637	)
Net loss		—		—		—		—			(639,185	)		(639,185	)
Balance, December 31, 2020		250,798,723	$	2,509	$	9,998,635	$	(30,622	)	$	(11,874,881	)	$	(1,904,359	)
Shares issued in connection with the sale of common stock		—		—		30,476		—			—			30,476
Beneficial conversion discount on convertible notes payable		—		—		43,475		—			—			43,475
Stock-based compensation expense		3,688,596		37		3,422,463		—			—			3,422,500
Foreign currency translation adjustment		—		—		—		15,312			—			15,312
Net loss		—		—		—		—			(3,597,837	)		(3,597,837	)
Balance, March 31, 2021		254,487,319	$	2,546	$	13,495,049	$	(15,310	)	$	(15,472,718	)	$	(1,990,433	)

	Common Stock				Additional		Other						Total
			Par		Paid-in		Comprehensive			Accumulated			Stockholders’
	Shares		Value		Capital		Income			Deficit			Deficiency
Balance September 30, 2019		242,449,767		2,424		9,047,139		100,717			(10,132,535	)		(982,255	)
Shares issued in connection with the sale of common stock		153,333		3		52,999		—			—			53,002
Debt Discount on Convertible Notes		—		—		68,220		—			—			68,220
Foreign currency translation adjustment		—		—		—		(21,101	)		—			(21,101	)
Net Loss		—		—		—		—			(240,654	)		(240,654	)
Balance December 31, 2019		242,603,100	$	2,427	$	9,168,358	$	79,616		$	(10,373,189	)	$	(1,122,788	)
Shares issued in connection with the sale of common stock		356,467		3		15,781		—			—			15,784
Stock-based compensation expense		—		—		—		—			—			—
Debt Discount on Convertible Notes		—		—		—		—			—			—
Foreign currency translation adjustment		—		—		—		76,505			—			76,505
Net Loss		—		—		—		—			(176,900	)		(176,900	)
Balance March 31, 2020		242,959,567	$	2,430	$	9,184,139	$	156,121		$	(10,550,089	)	$	(1,207,399	)

The accompanying notes are an integral part of these consolidated financial statements.

5

GRAPHENE & SOLAR TECHNOLOGIES Limited 

CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS

For the Six-Month Period Ended March 31, 2021 and 2020

(Unaudited)

	2021			2020
Cash flows from operating activities
Net Income (loss)	$	(4,237,022	)	$	(417,554	)
Adjustments to reconcile net income/(loss) to net cash from operating activities:
Stock-based compensation		3,827,500			—
Depreciation expense		8,986			8,066
Amortization of discount		12,582			10,919
Change in operating assets and liabilities:
Accounts payable		131,957			127,125
Accrued interest payable		14,603			11,463
Receivables		—			442
Pre-Payments		(15,723	)		(256	)
Due to related parties		93,041			112,700
Net cash used in operating activities		(164,076	)		(147,095	)
Cash flows from financing activities
Due to Affiliates		—			—
Proceeds from issuance of common stock		115,214			68,786
Repayments to related party		—			(53,821	)
Issuance of short term note payable, net of OID		115,000			68,220
Net cash from financing activities		230,214			83,185
Effect of currency translations to cash flow		(66,003	)		(8,445	)
Net change in cash and cash equivalents		135			(72,355	)
Beginning of period		12			74,241
End of period	$	147		$	1,886

Supplemental cash flow information	Quarter ended March 31,
	2021		2020
Interest paid	$	—	$	—
Taxes	$	—	$	—
Noncash investing and financing activities:
Debt discount on convertible notes		43,475		68,220
Conversion of loan principal into shares	$	—	$	—

The accompanying notes are an integral part of these consolidated financial statements.

6

GRAPHENE & SOLAR TECHNOLOGIES Limited 

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

NOTE 1 – BASIS OF PRESENTATION

These consolidated financial statements of Graphene &Solar Technologies Limited (GSTX or the Company) have been prepared in accordance with accounting principles generally accepted in the United States of America (U.S. GAAP). In the opinion of management, these financial statements include all adjustments, consisting only of normal recurring adjustments, necessary for a fair statement of the results for the interim periods. Certain information, accounting policies and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been omitted pursuant to Securities and Exchange Commission (SEC) rules and regulations. These financial statements should be read along with Solar Quartz’s audited financial statements as of September 30, 2020.

Going Concern – The Company has incurred cumulative net losses throughout 2019 and 2020 financial periods and currently in 2021 periods. Accordingly, it requires capital to fund working capital deficits and for future operating activities to take place. The Company’s ability to raise new funds through the future issuances of debt or common stock is unknown. The obtainment of additional financing, the successful development of a plan of operations, and its transition, ultimately, to the attainment of profitable operations are necessary for the Company to continue operations. The ability to successfully resolve these factors raise substantial doubt about the Company’s ability to continue as a going concern.

Going Concern – The Company has incurred cumulative net losses since inception of $15,472,718 at March 31, 2021. Accordingly, it requires capital to fund working capital deficits and for future operating activities to take place. The Company’s ability to raise new funds through the future issuances of debt or common stock is unknown. The obtainment of additional financing, the successful development of a plan of operations, and its transition, ultimately, to the attainment of profitable operations are necessary for the Company to continue operations. The ability of the Company to continue its operations is dependent on management’s plans, which include the raising of capital through debt and/or equity markets, with some additional funding from other traditional financing sources, including term notes, until such time that funds provided by operations are sufficient to fund working capital requirements. The Company may need to incur additional liabilities with certain related parties to sustain the Company’s existence. There can be no assurance that the Company will be able to raise any additional capital and therefore raise doubt about the Company’s ability to continue as a going concern.

Future issuances of the Company’s equity or debt securities will be required for the Company to finance operations and continue as a going concern. The financial statements do not include any adjustments that may result from the outcome of these uncertainties.

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PRESENTATION

Principles of Consolidation and Basis of Presentation — The consolidated financial statements include the accounts of Graphene & Solar Technologies Limited and its subsidiary. All significant intercompany accounts and transactions have been eliminated in consolidation.

The accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the accounting and disclosure rules and regulations of the U.S. Securities and Exchange Commission (“SEC”). A summary of the significant accounting policies applied in the preparation of the accompanying financial statements can be found in the Company’s Annual Report in form 10-K for the year ended September 30, 2020.

Use of Estimates - The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

7

Significant estimates include but are not limited to the estimated useful lives of equipment for purposes of depreciation and the valuation of common shares issued for services, equipment and the liquidation of liabilities.

Cash and Cash Equivalents-Cash and cash equivalents are carried at cost and represent cash on hand, demand deposits placed with banks or other financial institutions and all highly liquid investments with an original maturity of three months or less as of the purchase date of such investments. As of March 31, 2021 and 2020, the Company had $147 and $1,886 in cash, respectively, and no cash equivalents.

Concentrations - As of March 31, 2021, there were no known concentrations other than those identified in Note 3 and Note 4 below.

Derivative Financial Instruments – The Company accounts for freestanding contracts that are settled in a company’s own stock, including common stock warrants, to be designated as an equity instrument or generally as a liability. A contract so designated is carried at fair value on a company’s balance sheet, with any changes in fair value recorded as a gain or loss in a company’s results of operations.

The Company records all derivatives on the balance sheet at fair value, adjusted at the end of each reporting period to reflect any material changes in fair value, with any such changes classified as changes in derivatives valuation in the statement of operations. The calculation of the fair value of derivatives utilizes highly subjective and theoretical assumptions that can materially affect fair values from period to period. The recognition of these derivative amounts does not have any impact on cash flows.

At the date of the conversion of any convertible debt, the pro rata fair value of the related embedded derivative liability is transferred to additional paid-in capital.

There was no derivative activity in fiscal quarter ending March 31, 2020. Therefore, no derivative liabilities were recorded during the quarter ended March 31, 2021.

Stock-Based Compensation -ASC 718, “Compensation - Stock Compensation,” prescribes accounting and reporting standards for all share-based payment transactions in which employee and non-employee services are acquired. Transactions include incurring liabilities, or issuing or offering to issue shares, options and other equity instruments such as employee stock ownership plans and stock appreciation rights. Share-based payments to employees and non-employees, including grants of employee stock options, are recognized as compensation expense in the financial statements based on their fair values on the grant date. That expense is recognized over the period during which an employee is required to provide services in exchange for the award, known as the requisite service period (usually the vesting period).

During the quarter ended March 31, 2021, the Company issued 3,688,596 shares of the Company’s common stock to consultants. Since September 30,2020 the Company has issued a total of 6,788,596 shares of the Company’s common stock to consultants. The fair value of the shares, as determined by reference market price of the Company’s common stock on each grant date, during the quarter ended March 31, 2021aggregated $3,422,500.

During the quarter ended March 31, 2019, the Company issued no shares of the Company’s common stock to members of the Board of Directors, employees and consultants.

Total stock-based compensation expense was $3,827,450 and $0 for the quarters ended March 31, 2021 and 2020, respectively.

Foreign Currency Translations – The functional currency of the Company’s foreign subsidiary is primarily the respective local currency. Assets and liabilities of the Company’s foreign subsidiary are translated into U.S. Dollars at the year-end exchange rate, and revenues and expenses are translated at average monthly exchange rates. Translation gains and losses are recorded as a component of accumulated other comprehensive income (loss) within stockholders’ equity. All other foreign currency transaction gains and losses are included in other (income) expense, net.

8

Earnings Per Share - Basic earnings per share have been calculated based upon the weighted-average number of common shares outstanding. Diluted earnings per share were not calculated as such potential shares would be anti-dilutive.

Reclassifications - Certain amounts previously presented for prior periods have been reclassified to conform to the current presentation. The reclassifications had no effect on net loss, working capital or equity previously reported.

NOTE 3 – CONVERTIBLE NOTES PAYABLE

The Company’s indebtedness as of March 31,2021 and September 30, 2020 were as follows:

Description	March 31, 2021		September 30, 2020
Convertible notes	$	202,292	$	168,967
Notes Payable	$	60,000	$	60,000
Other loans		5,781		5,632

Notes Payable and Other Loans

During 2015 and 2016, the Company executed promissory notes payable with six individuals with an aggregate principal balance of $60,000. The notes were due on demand and included interest at 10%. As of March 31, 2021 and September 30, 2020, the total promissory notes payable balance was $93,701 and $90,710 including accrued interest of $33,701 and $30,710, respectively. On January 15, 2019, the holder of a note with a principal balance of $10,000 made demand for payment. To date, the note has not been paid.

During the year ended September 30, 2020 a Company Advisor, loaned the Company $5,781. The loan is a demand note at zero interest.

Convertible Notes Payable

As of March 31, 2021 and September 30, 2020, noteholders representing $70,747 in outstanding principal had not requested the exchange of shares of common stock. As of March 31, 2021 and September 30, 2020, the exchange obligation payable was $152,965 and $147,673 including accrued interest of $82,217 and $76,926, respectively. As of March 31, 2020 and September 30, 2020, the exchange obligation was for 46,213 shares and 44,614 shares of common stock, respectively.

On February 1, 2016, the Company issued convertible secured note payable of $30,000 to an individual. The note was due on January 31, 2017 and included interest at 10%. The note was convertible at discretion of the holder into common shares of the Company at the rate of $0.50 per shares. The Company has not extended the maturity date and the note is in default. As of March 31, 2021 and September 30, 2020, the total convertible note payable balance was $46,223 and $43,997, including accrued interest of $16,233 and $13,997 respectively. As of March 31, 2021 and 2019, the exchange obligation was for 92,446 shares and 87,994 shares of common stock, respectively.

On December 5, 2019, the Company issued a convertible note payable in the amount of $68,220. The convertible note bear interest at 10% and matures on December 5, 2021 the principal and accrued interest of this convertible note can be converted at the discretion of the holder into common shares at 45% discount to the ADR 20 days prior to notification of conversion. The majority shareholder agreed to increase authorized shares if needed in order to settle this debt. This note was discounted for the full amount and the amount of amortization during the period was $7,430.

9

On October 2, 2020, the Company closed a Securities Purchase Agreement with Geneva Roth Remark Holdings Inc (“GRRH”). In connection therewith, the Company issued GRRH a convertible note payable in the amount of $68,000. The note, including interest at 10%, matures on September 24, 2020. After 180 days, being from March 23, 2021, the note is convertible at a conversion price which is at 39% discount to the lowest trading price during the previous twenty trading days prior to the date of a conversion notice. The note contained an original issue discount of $3,000.

The majority shareholder agreed to increase authorized shares if needed in order to settle this debt. This note was discounted $43,475 as at March 23, 2021 and the amount of amortization during the period was $1.932.

On November 11, 2020, the Company closed a Securities Purchase Agreement with Geneva Roth Remark Holdings Inc (“GRRH”). In connection therewith, the Company issued GRRH a convertible note payable in the amount of $53,000. The note, including interest at 10%, matures on November 11, 2020. After 180 days, the note is convertible at a conversion price which is at 39% discount to the lowest trading price during the previous twenty trading days prior to the date of a conversion notice. As the conversion date had not become effective as of March 31, 2021 no derivative liability was recorded. The note contained an original issue discount of $3,000. There was no amortization expense recognized during the period.

10

NOTE 4- RELATED PARTY

PGRNZ Limited, a management company controlled by the Company’s Chief Executive Officer, and a Company Director, provides management services to the Company for which the Company is charged $75,000(AUD) quarterly, approximately $56,250 (US). During the three months ended March 31, 2021 and 2020, the Company incurred charges to operations of $16,888 (US) and $16,888 (US), respectively, with respect to this arrangement.

As of March 31, 2021 and September 30, 2020, accrued expenses due to PGRNZ and other related parties was $810,116 and $717,075 respectively.

NOTE 5 – STOCKHOLDERS’ EQUITY

Other than for Stock based compensation (see Note 2), 1,450,000 new common shares were issued during the six month period ending March 31, 2021 for proceeds totaling $115,214.

The Company has a total of 5,778,366 shares that remain approved, reserved and outstanding and not yet issued by the Transfer Agent at March 31, 2021

NOTE 6 – COMMITMENTS & CONTINGENCIES

Contingencies

From time to time, we may be involved in routine legal proceedings, as well as demands, claims and threatened litigation that arise in the normal course of our business. The ultimate amount of liability, if any, for any claims of any type (either alone or in the aggregate) may materially and adversely affect our financial condition, results of operations and liquidity. In addition, the ultimate outcome of any litigation is uncertain. Any outcome, whether favorable or unfavorable, may materially and adversely affect us due to legal costs and expenses, diversion of management attention and other factors. We expense legal costs in the period incurred. We cannot assure you that additional contingencies of a legal nature or contingencies having legal aspects will not be asserted against us in the future, and these matters could relate to prior, current or future transactions or events. As of March 31, 2021, there were no pending or threatened litigation against the Company.

NOTE 7 – SUBSEQUENT EVENTS

During the month of April 2021 additional Common shares of 450,000 were approved at a share price of approximately $0.05 and Commons shares of 100,000 were approved for Stock based compensation to a company advisor at $0.50.

11

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND PLAN OF OPERATION

The following discussion of our financial condition and results of operations should be read in conjunction with our financial statements and the related notes, and other financial information included in this Form 10-Q.

Our Management’s Discussion and Analysis contains not only statements that are historical facts, but also statements that are forward-looking. Forward-looking statements are, by their very nature, uncertain and risky. Although the forward-looking statements in this Quarterly Report reflect the good faith judgment of our management, such statements can only be based on facts and factors currently known by them. Consequently, and because forward-looking statements are inherently subject to risks and uncertainties, the actual results and outcomes may differ materially from the results and outcomes discussed in the forward-looking statements. You are urged to carefully review and consider the various disclosures made by us in this report as we attempt to advise interested parties of the risks and factors that may affect our business, financial condition, and results of operations and prospects.

FORWARD LOOKING STATEMENTS

The information contained in this Form 10-Q contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. These forward-looking statements involve risks and uncertainties, including among other things, statements regarding our capital needs, business strategy and expectations. Any statement which does not contain a historical fact may be deemed to be a forward-looking statement. In some cases, you can identify forward-looking statements by terminology such as “may”, “will”, “should”, “expect”, “plan”, “intend”, “anticipate”, “believe”, “estimate”, “predict”, “potential” or “continue”, the negative of such terms or other comparable terminology. In evaluating forward looking statements, you should consider various factors outlined in our Form 10-K report for the year ended September 30, 2019, filed with the U.S. Securities Exchange Commission (“SEC”) and, from time to time, in other reports we file with the SEC. These factors may cause our actual results to differ materially from any forward-looking statement. We disclaim any obligation to publicly update these statements or disclose any difference between our actual results and those reflected in these statements.

Overview

In July 2017 we acquired Solar Quartz Technologies Limited, a New Zealand corporation. We continue to seek new financing in the form of equity, debt or a combination thereof to meet development and general operating obligations. Absent achieving sufficient funds soon, our viability is in doubt. The Company has managed to raise some capital by sale of shares, but as of March 31, 2021, the Company has not been successful in raising sufficient funds; However, work is underway to secure funding, and we believe that funding for the Company is possible in the near future although no assurance can be made as to the amount of funds, if any, or the terms thereof.

Current Business and Operations

We continue to develop our detailed plans for multi-faceted production facilities in Queensland Australia to enable us to process raw high purity quartz from the region into higher value high purity quartz products and sands (HPQS). Further work is proceeding in respect to graphene production capability and business planning on thin film capability.

We are currently actively seeking interim working capital in order to complete mining plans and build a pre-processing plant in Townsville, North Queensland, Australia, build upon our management team and market high purity quartz (HPQS) to established markets with whom our management team have had prior relationships. These organizational efforts will be to secure significant new capital for the acquisition of a site and the building of the pre-processing plant. Upon completion, that plant will enable the Company to upgrade its newly mined HPQS to a higher level of purity that has a significant world-wide demand for use in the production of advanced PV solar Panels and all high-end electronics, lighting, telecom, optic and microelectronics. Failure to secure these financings will have a negative impact on the Company’s ability to continue as a going concern.

12

Results of Operations

For the fiscal quarters ended March 31, 2021 and 2020 we generated no revenues, and thus no cost of sales or gross profits.

For the fiscal quarters ended March 31, 2021 and 2020, we incurred $3,584,604 and $163,796 respectively in operating expenses.

For the fiscal quarter ended March 31, 2021 we recorded other expenses of $13,233 while in March 31, 2020 we incurred expenses of $13,104 both items are represented by accrued interest on debt. Other income of $2,318 was earned in the fiscal quarter, March 31, 2021.

For the six months ended March 31, 2021, we reported net loss before taxes of $4,237,022 while in the six months ended March 31, 2020, we reported a net loss before taxes of $362,150. Since there were no tax obligations in either year, net income / loss in each year was the same as that reported before taxes.

For the periods ended September 30, 2020 and March 31, 2021, our cash positions were $12 and $147 respectively.

As of March 31, 2021, we had total current liabilities of $2,010,324 while as of September 30, 2020, we had total current liabilities of $1,684,546 an increase of about 19%. Accrued interest payable increased from $132,099 to $146,702 all attributable to accruals on the loans and the convertible notes payable.

Liquidity and Capital Resources

As of March 31, 2021, we had $15,870 in total current assets and $2,010,324 in total current liabilities. Accordingly, we had a working capital deficit of $1,994,454.

Operating activities used $164,076 in cash for the quarter ended March 31, 2021, as compared to $147,095 for the quarter ended March 31, 2020.

13

Off-Balance Sheet Arrangements

There are no off-balance sheet arrangements.

Critical Accounting Policies and Estimates

For a discussion of our accounting policies and related items, please see the Notes to the Financial Statements, included in Item 1.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURE ABOUT MARKET RISK.

Not applicable.

ITEM 4. CONTROLS AND PROCEDURES.

Evaluation of Disclosure Controls and Procedures

An evaluation was carried out under the supervision and with the participation of our management, including our Principal Executive and Interim Financial Officer, of the effectiveness of our disclosure controls and procedures as of the end of the period covered by this report on Form 10-Q. Disclosure controls and procedures are procedures designed with the objective of ensuring that information required to be disclosed in our reports filed under the Securities Exchange Act of 1934, such as this Form 10-Q, is recorded, processed, summarized and reported, within the time period specified in the Securities and Exchange Commission’s rules and forms, and that such information is accumulated and is communicated to our management, including our Principal Executive [and Financial Officer], or persons performing similar functions, as appropriate, to allow timely decisions regarding required disclosure. Based on that evaluation, our management concluded that, as of December 31, 2020, our disclosure controls and procedures were not effective.

Management conducted an evaluation of the effectiveness of our internal control over financial reporting as of December 31, 2020, based on the framework established in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission in 2013 (“COSO”).

As of period covered by this Quarterly Report on Form 10-Q, we have concluded that our internal control over financial reporting was ineffective. The Company’s assessment identified certain material weaknesses which are set forth below:

Functional Controls and Segregation of Duties

Because of the Company’s limited resources, there are limited controls over information processing.

There is an inadequate segregation of duties consistent with control objectives. Our Company’s management is composed of a small number of individuals resulting in a situation where limitations on segregation of duties exist. In order to remedy this situation, we would need to hire additional staff to provide greater segregation of duties. Currently, it is not feasible to hire additional staff to obtain optimal segregation of duties. Management will reassess this matter in the following year to determine whether improvement in segregation of duty is feasible.

Accordingly, as the result of identifying the above material weakness we have concluded that these control deficiencies resulted in a reasonable possibility that a material misstatement of the annual or interim financial statements will not be prevented or detected on a timely basis by the Company’s internal controls.

14

Management’s Report on Internal Control over Financial Reporting

Our management is responsible for establishing and maintaining adequate internal control over financial reporting and for the assessment of the effectiveness of internal control over financial reporting. As defined by the Securities and Exchange Commission, internal control over financial reporting is a process designed by, or under the supervision of our Principal Executive and Financial Officer and implemented by our Board of Directors, management and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of our financial statements in accordance with U.S. generally accepted accounting principles.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

Roger May, our Principal Executive Officer, evaluated the effectiveness of our internal control over financial reporting as of March 31, 2021 based on criteria established in Internal Control - Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission, or the COSO Framework (2013). Management’s assessment included an evaluation of the design of our internal control over financial reporting and testing of the operational effectiveness of those controls.

Changes in Internal Control Over Financial Reporting

There was no change in our internal control over financial reporting that occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

Management has addressed the underlying causes for our weaknesses in internal control since early FY 2020. Our efforts to raise both debt and equity capital soon will allow us to undertake additional engagement of external independent consultants to assist with the processing of data and drafting financial reports on a timely basis in future reporting periods.

15

PART II

ITEM 1. LEGAL PROCEEDINGS

None.

ITEM 1A. RISK FACTORS

Our business is subject to numerous risks and uncertainties including but not limited to those discussed in “Risk Factors” in our annual report on Form 10-K.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

Please see Note 5 to our Financial Statements.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4. MINE SAFETY DISCLOSURES

None.

ITEM 5. OTHER INFORMATION

None.

ITEM 6. EXHIBITS

Exhibits

31.1	Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2	Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32	Certification pursuant to Section 906 of the Sarbanes-Oxley Act.

16

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	GRAPHENE & SOLAR TECHNOLOGIES LIMITED
Date: May 26, 2021	By:	/s/ Roger May
		Chief Executive Officer and Director

17

EX-31.1

EXHIBIT 31.1

CERTIFICATIONS

I, Roger May, certify that;

1.	I have reviewed this quarterly report on Form 10-Q of Graphene & Solar Technologies Limited;
2.	Based on my knowledge, this report, does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by the report;
3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.	The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b)	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)	Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d)	Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a)	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b)	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 26, 2021	By:	/s/ Roger May
		Roger May
		Chief Executive Officer and Director

EX-31.2

EXHIBIT 31.2

CERTIFICATIONS

I, David AB Halstead, certify that;

1.	I have reviewed this quarterly report on Form 10-Q of Graphene & Solar Technologies Limited;
2.	Based on my knowledge, this report, does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by the report;
3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.	The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b)	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)	Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d)	Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a)	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b)	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 26, 2021	By:	/s/ David AB Halstead
		David AB Halstead Director and Interim Chief Financial Officer

EX-32.1

EXHIBIT 32.1

In connection with the Quarterly Report of Graphene & Solar Technologies Limited (the “Company”) on Form 10-Q for the period ending March 31, 2021 as filed with the Securities and Exchange Commission (the “Report”), Roger May, the Chief Executive Officer and Director of the Company, certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of his knowledge:

(1)	The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)	The information contained in the Report fairly presents, in all material respects the financial condition and results of operations of the Company.

Date: May 26, 2021	By:	/s/ Roger May
		Roger May
		Chief Executive Officer and Director

EX-32.2

EXHIBIT 32.2

In connection with the Quarterly Report of Graphene & Solar Technologies Limited (the “Company”) on Form 10-Q for the period ending March 31, 2021 as filed with the Securities and Exchange Commission (the “Report”), David A.B. Halstead, the Director and Interim Chief Financial Officer of the Company, certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of his knowledge:

(1)	The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)	The information contained in the Report fairly presents, in all material respects the financial condition and results of operations of the Company.

Date: May 26, 2021	By:	/s/ David Halstead
		David Halstead,
		Director and Interim Chief Financial Officer

XML

Cover - shares	6 Months Ended
	Mar. 31, 2021	May 26, 2021
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Mar. 31, 2021
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2021
Current Fiscal Year End Date	--09-30
Entity File Number	333-174194
Entity Registrant Name	GRAPHENE & SOLAR TECHNOLOGIES LTD
Entity Central Index Key	0001497649
Entity Tax Identification Number	27-2888719
Entity Incorporation, State or Country Code	CO
Entity Address, Address Line One	23 Corporate Plaza Drive
Entity Address, Address Line Two	Suite 150
Entity Address, City or Town	Newport Beach
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	92660
City Area Code	949
Local Phone Number	432-7525
Entity Current Reporting Status	Yes
Entity Interactive Data Current	No
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Elected Not To Use the Extended Transition Period	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		255,037,319

XML

Condensed Consolidated Balance Sheets - USD ($)	Mar. 31, 2021	Sep. 30, 2020
Current Assets:
Cash	$ 147	$ 12
Prepaid expenses	15,723
Total Current Assets	15,870	12
Other Assets:
Furniture & Equipment, net of depreciation, $8,986 and $71,803	4,021	12,259
Total Other Assets	4,021	12,259
Total Assets	19,891	12,271
Current Liabilities:
Accounts payable and other payable	785,433	653,476
Accrued interest payable	146,702	132,099
Notes payable-in default	60,000	60,000
Due to related parties	810,116	717,075
Convertible notes payable-, net of discount $86,381and $52,703 in default	202,292	116,264
Other loans	5,781	5,632
Total Current Liabilities	2,010,324	1,684,546
Total Liabilities	2,010,324	1,684,546
Stockholders’ Deficit:
Common stock, $0.00001 par value; 500,000,000 and 500,000,000 shares authorized; 254,487,319 and 246,248,723 shares issued and outstanding	2,546	2,463
Additional paid-in capital	13,495,049	9,508,943
Accumulated other comprehensive income	(15,310)	52,015
Accumulated deficit	(15,472,718)	(11,235,696)
Total stockholders’ deficit	(1,990,433)	(1,672,275)
Total liabilities and stockholders’ deficit	$ 19,891	$ 12,271

XML

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)	Mar. 31, 2021	Sep. 30, 2020
Statement of Financial Position [Abstract]
Furniture & Equipment, net of depreciation	$ 8,986	$ 71,803
Debt Instrument, Unamortized Discount, Current	$ 86,381	$ 52,703
Preferred stock, par value	$ 0.00001	$ 0.00001
Preferred shares, authorized	10,000,000	10,000,000
Preferred stock, issued	0	0
Preferred stock, outstanding	0	0
Common stock, par value	$ 0.00001	$ 0.00001
Common stock, authorized	500,000,000	500,000,000
Common stock, issued	254,487,319	246,248,723
Common stock,outstanding	254,487,319	246,248,723

XML

Condensed Consolidated Statements of Operations and Other Comprehensive Income - USD ($)	3 Months Ended		6 Months Ended
	Mar. 31, 2021	Mar. 31, 2020	Mar. 31, 2021	Mar. 31, 2020
Income Statement [Abstract]
Revenues
Costs and expenses
Professional Services	3,545,803	134,237	4,130,354	313,724
General and administrative	38,801	29,559	81,350	85,410
Total costs and expenses	3,584,604	163,796	4,211,704	399,134
Loss from operations	(3,584,604)	(163,796)	(4,211,704)	(399,134)
Other income (expense) Other income
Interest expense	(15,551)	(15,079)	(29,827)	(22,445)
Total other income (expense)	(13,233)	(13,104)	(25,318)	(18,420)
Net Income (Loss)	(3,597,837)	(176,900)	(4,237,022)	(417,554)
Comprehensive income (Loss)	15,312	76,505	(67,325)	55,404
Net Comprehensive Income (Loss)	$ (3,582,525)	$ (100,395)	$ (4,304,347)	$ (362,150)
Income (Loss) per share:
Basic and diluted	$ (0.01)	$ (0.00)	$ (0.02)	$ (0.00)
Weighted average shares outstanding	253,168,937	242,953,034	251,406,796	242,626,956

XML

Condensed Consolidated Statements of Stockholders Deficit - USD ($)	Common Stock [Member]	Additional Paid-in Capital [Member]	AOCI Attributable to Parent [Member]	Retained Earnings [Member]	Total
Beginning balance, value at Sep. 30, 2019	$ 2,424	$ 9,047,139	$ 100,717	$ (10,132,535)	$ (982,255)
Common Stock, Shares, Outstanding, Beginning Balance at Sep. 30, 2019	242,449,767
Shares issued in connection with the sale of common stock	$ 3	52,999			53,002
Stock Issued During Period, Shares, New Issues	153,333
Foreign currency translation adjustment			(21,101)		(21,101)
Net Loss				(240,654)	(240,654)
Common Stock, Shares, Outstanding, Ending Balance at Dec. 31, 2019	242,603,100
Ending balance, value at Dec. 31, 2019	$ 2,427	9,168,358	79,616	(10,373,189)	(1,122,788)
Debt Discount on Convertible Notes		68,220			68,220
Beginning balance, value at Sep. 30, 2019	$ 2,424	9,047,139	100,717	(10,132,535)	(982,255)
Common Stock, Shares, Outstanding, Beginning Balance at Sep. 30, 2019	242,449,767
Net Loss					(417,554)
Common Stock, Shares, Outstanding, Ending Balance at Mar. 31, 2020	242,959,567
Ending balance, value at Mar. 31, 2020	$ 2,430	9,184,139	156,121	(10,550,089)	(1,207,399)
Debt Discount on Convertible Notes					68,220
Beginning balance, value at Dec. 31, 2019	$ 2,427	9,168,358	79,616	(10,373,189)	(1,122,788)
Common Stock, Shares, Outstanding, Beginning Balance at Dec. 31, 2019	242,603,100
Shares issued in connection with the sale of common stock	$ 3	15,781			15,784
Stock Issued During Period, Shares, New Issues	356,467
Stock-based compensation expense
Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture
Foreign currency translation adjustment			76,505		76,505
Net Loss				(176,900)	(176,900)
Common Stock, Shares, Outstanding, Ending Balance at Mar. 31, 2020	242,959,567
Ending balance, value at Mar. 31, 2020	$ 2,430	9,184,139	156,121	(10,550,089)	(1,207,399)
Debt Discount on Convertible Notes
Beginning balance, value at Sep. 30, 2020	$ 2,463	9,508,943	52,015	(11,235,696)	$ (1,672,275)
Common Stock, Shares, Outstanding, Beginning Balance at Sep. 30, 2020	246,248,723				246,248,723
Shares issued in connection with the sale of common stock	$ 15	84,723			$ 84,738
Stock Issued During Period, Shares, New Issues	1,450,000
Stock-based compensation expense	$ 31	404,969			405,000
Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture	3,100,000
Foreign currency translation adjustment			(82,637)		(82,637)
Net Loss				(639,185)	(639,185)
Common Stock, Shares, Outstanding, Ending Balance at Dec. 31, 2020	250,798,723
Ending balance, value at Dec. 31, 2020	$ 2,509	9,998,635	(30,622)	(11,874,881)	(1,904,359)
Beginning balance, value at Sep. 30, 2020	$ 2,463	9,508,943	52,015	(11,235,696)	$ (1,672,275)
Common Stock, Shares, Outstanding, Beginning Balance at Sep. 30, 2020	246,248,723				246,248,723
Net Loss					$ (4,237,022)
Common Stock, Shares, Outstanding, Ending Balance at Mar. 31, 2021	254,487,319				254,487,319
Ending balance, value at Mar. 31, 2021	$ 2,546	13,495,049	(15,310)	(15,472,718)	$ (1,990,433)
Debt Discount on Convertible Notes					43,475
Beginning balance, value at Dec. 31, 2020	$ 2,509	9,998,635	(30,622)	(11,874,881)	(1,904,359)
Common Stock, Shares, Outstanding, Beginning Balance at Dec. 31, 2020	250,798,723
Shares issued in connection with the sale of common stock		30,476			30,476
Stock Issued During Period, Shares, New Issues
Stock-based compensation expense	$ 37	3,422,463			3,422,500
Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture	3,688,596
Foreign currency translation adjustment			15,312		15,312
Net Loss				(3,597,837)	$ (3,597,837)
Common Stock, Shares, Outstanding, Ending Balance at Mar. 31, 2021	254,487,319				254,487,319
Beneficial conversion discount on convertible notes payable		43,475			$ 43,475
[custom:BeneficialConversionDiscount]
Ending balance, value at Mar. 31, 2021	$ 2,546	$ 13,495,049	$ (15,310)	$ (15,472,718)	$ (1,990,433)

XML

Condensed Consolidated Statement of Cash Flows - USD ($)	6 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Cash flows from operating activities
Net Income (loss)	$ (4,237,022)	$ (417,554)
Adjustments to reconcile net income/(loss) to net cash from operating activities:
Stock-based compensation	3,827,500
Depreciation expense	8,986	8,066
Amortization of discount	12,582	10,919
Change in operating assets and liabilities:
Accounts payable	131,957	127,125
Accrued interest payable	14,603	11,463
Receivables		442
Pre-Payments	(15,723)	(256)
Due to related parties	93,041	112,700
Net cash used in operating activities	(164,076)	(147,095)
Cash flows from financing activities
Due to Affiliates
Proceeds from issuance of common stock	115,214	68,786
Repayments to related party		(53,821)
Issuance of short term note payable, net of OID	115,000	68,220
Net cash from financing activities	230,214	83,185
Effect of currency translations to cash flow	(66,003)	(8,445)
Net change in cash and cash equivalents	135	(72,355)
Beginning of period	12	74,241
End of period	147	1,886
Supplemental cash flow information
Interest paid
Taxes
Noncash investing and financing activities:
Debt discount on convertible notes	43,475	68,220
Conversion of loan principal into shares

XML

BASIS OF PRESENTATION

6 Months Ended

Mar. 31, 2021

Accounting Policies [Abstract]

BASIS OF PRESENTATION

NOTE 1 – BASIS OF PRESENTATION

These consolidated financial statements of Graphene &Solar Technologies Limited (GSTX or the Company) have been prepared in accordance with accounting principles generally accepted in the United States of America (U.S. GAAP). In the opinion of management, these financial statements include all adjustments, consisting only of normal recurring adjustments, necessary for a fair statement of the results for the interim periods. Certain information, accounting policies and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been omitted pursuant to Securities and Exchange Commission (SEC) rules and regulations. These financial statements should be read along with Solar Quartz’s audited financial statements as of September 30, 2020.

Going Concern – The Company has incurred cumulative net losses throughout 2019 and 2020 financial periods and currently in 2021 periods. Accordingly, it requires capital to fund working capital deficits and for future operating activities to take place. The Company’s ability to raise new funds through the future issuances of debt or common stock is unknown. The obtainment of additional financing, the successful development of a plan of operations, and its transition, ultimately, to the attainment of profitable operations are necessary for the Company to continue operations. The ability to successfully resolve these factors raise substantial doubt about the Company’s ability to continue as a going concern.

Going Concern – The Company has incurred cumulative net losses since inception of $15,472,718 at March 31, 2021. Accordingly, it requires capital to fund working capital deficits and for future operating activities to take place. The Company’s ability to raise new funds through the future issuances of debt or common stock is unknown. The obtainment of additional financing, the successful development of a plan of operations, and its transition, ultimately, to the attainment of profitable operations are necessary for the Company to continue operations. The ability of the Company to continue its operations is dependent on management’s plans, which include the raising of capital through debt and/or equity markets, with some additional funding from other traditional financing sources, including term notes, until such time that funds provided by operations are sufficient to fund working capital requirements. The Company may need to incur additional liabilities with certain related parties to sustain the Company’s existence. There can be no assurance that the Company will be able to raise any additional capital and therefore raise doubt about the Company’s ability to continue as a going concern.

Future issuances of the Company’s equity or debt securities will be required for the Company to finance operations and continue as a going concern. The financial statements do not include any adjustments that may result from the outcome of these uncertainties.

XML

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PRESENTATION

6 Months Ended

Mar. 31, 2021

Accounting Policies [Abstract]

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PRESENTATION

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PRESENTATION

Principles of Consolidation and Basis of Presentation — The consolidated financial statements include the accounts of Graphene & Solar Technologies Limited and its subsidiary. All significant intercompany accounts and transactions have been eliminated in consolidation.

The accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the accounting and disclosure rules and regulations of the U.S. Securities and Exchange Commission (“SEC”). A summary of the significant accounting policies applied in the preparation of the accompanying financial statements can be found in the Company’s Annual Report in form 10-K for the year ended September 30, 2020.

Use of Estimates - The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Significant estimates include but are not limited to the estimated useful lives of equipment for purposes of depreciation and the valuation of common shares issued for services, equipment and the liquidation of liabilities.

Cash and Cash Equivalents-Cash and cash equivalents are carried at cost and represent cash on hand, demand deposits placed with banks or other financial institutions and all highly liquid investments with an original maturity of three months or less as of the purchase date of such investments. As of March 31, 2021 and 2020, the Company had $147 and $1,886 in cash, respectively, and no cash equivalents.

Concentrations - As of March 31, 2021, there were no known concentrations other than those identified in Note 3 and Note 4 below.

Derivative Financial Instruments – The Company accounts for freestanding contracts that are settled in a company’s own stock, including common stock warrants, to be designated as an equity instrument or generally as a liability. A contract so designated is carried at fair value on a company’s balance sheet, with any changes in fair value recorded as a gain or loss in a company’s results of operations.

The Company records all derivatives on the balance sheet at fair value, adjusted at the end of each reporting period to reflect any material changes in fair value, with any such changes classified as changes in derivatives valuation in the statement of operations. The calculation of the fair value of derivatives utilizes highly subjective and theoretical assumptions that can materially affect fair values from period to period. The recognition of these derivative amounts does not have any impact on cash flows.

At the date of the conversion of any convertible debt, the pro rata fair value of the related embedded derivative liability is transferred to additional paid-in capital.

There was no derivative activity in fiscal quarter ending March 31, 2020. Therefore, no derivative liabilities were recorded during the quarter ended March 31, 2021.

Stock-Based Compensation -ASC 718, “Compensation - Stock Compensation,” prescribes accounting and reporting standards for all share-based payment transactions in which employee and non-employee services are acquired. Transactions include incurring liabilities, or issuing or offering to issue shares, options and other equity instruments such as employee stock ownership plans and stock appreciation rights. Share-based payments to employees and non-employees, including grants of employee stock options, are recognized as compensation expense in the financial statements based on their fair values on the grant date. That expense is recognized over the period during which an employee is required to provide services in exchange for the award, known as the requisite service period (usually the vesting period).

During the quarter ended March 31, 2021, the Company issued 3,688,596 shares of the Company’s common stock to consultants. Since September 30,2020 the Company has issued a total of 6,788,596 shares of the Company’s common stock to consultants. The fair value of the shares, as determined by reference market price of the Company’s common stock on each grant date, during the quarter ended March 31, 2021aggregated $3,422,500.

During the quarter ended March 31, 2019, the Company issued no shares of the Company’s common stock to members of the Board of Directors, employees and consultants.

Total stock-based compensation expense was $3,827,450 and $0 for the quarters ended March 31, 2021 and 2020, respectively.

Foreign Currency Translations – The functional currency of the Company’s foreign subsidiary is primarily the respective local currency. Assets and liabilities of the Company’s foreign subsidiary are translated into U.S. Dollars at the year-end exchange rate, and revenues and expenses are translated at average monthly exchange rates. Translation gains and losses are recorded as a component of accumulated other comprehensive income (loss) within stockholders’ equity. All other foreign currency transaction gains and losses are included in other (income) expense, net.

Earnings Per Share - Basic earnings per share have been calculated based upon the weighted-average number of common shares outstanding. Diluted earnings per share were not calculated as such potential shares would be anti-dilutive.

Reclassifications - Certain amounts previously presented for prior periods have been reclassified to conform to the current presentation. The reclassifications had no effect on net loss, working capital or equity previously reported.

XML

CONVERTIBLE NOTES PAYABLE

6 Months Ended

Mar. 31, 2021

Debt Disclosure [Abstract]

CONVERTIBLE NOTES PAYABLE

NOTE 3 – CONVERTIBLE NOTES PAYABLE

The Company’s indebtedness as of March 31,2021 and September 30, 2020 were as follows:

Description	March 31, 2021		September 30, 2020
Convertible notes	$	202,292	$	168,967
Notes Payable	$	60,000	$	60,000
Other loans		5,781		5,632

Notes Payable and Other Loans

During 2015 and 2016, the Company executed promissory notes payable with six individuals with an aggregate principal balance of $60,000. The notes were due on demand and included interest at 10%. As of March 31, 2021 and September 30, 2020, the total promissory notes payable balance was $93,701 and $90,710 including accrued interest of $33,701 and $30,710, respectively. On January 15, 2019, the holder of a note with a principal balance of $10,000 made demand for payment. To date, the note has not been paid.

During the year ended September 30, 2020 a Company Advisor, loaned the Company $5,781. The loan is a demand note at zero interest.

Convertible Notes Payable

As of March 31, 2021 and September 30, 2020, noteholders representing $70,747 in outstanding principal had not requested the exchange of shares of common stock. As of March 31, 2021 and September 30, 2020, the exchange obligation payable was $152,965 and $147,673 including accrued interest of $82,217 and $76,926, respectively. As of March 31, 2020 and September 30, 2020, the exchange obligation was for 46,213 shares and 44,614 shares of common stock, respectively.

On February 1, 2016, the Company issued convertible secured note payable of $30,000 to an individual. The note was due on January 31, 2017 and included interest at 10%. The note was convertible at discretion of the holder into common shares of the Company at the rate of $0.50 per shares. The Company has not extended the maturity date and the note is in default. As of March 31, 2021 and September 30, 2020, the total convertible note payable balance was $46,223 and $43,997, including accrued interest of $16,233 and $13,997 respectively. As of March 31, 2021 and 2019, the exchange obligation was for 92,446 shares and 87,994 shares of common stock, respectively.

On December 5, 2019, the Company issued a convertible note payable in the amount of $68,220. The convertible note bear interest at 10% and matures on December 5, 2021 the principal and accrued interest of this convertible note can be converted at the discretion of the holder into common shares at 45% discount to the ADR 20 days prior to notification of conversion. The majority shareholder agreed to increase authorized shares if needed in order to settle this debt. This note was discounted for the full amount and the amount of amortization during the period was $7,430.

On October 2, 2020, the Company closed a Securities Purchase Agreement with Geneva Roth Remark Holdings Inc (“GRRH”). In connection therewith, the Company issued GRRH a convertible note payable in the amount of $68,000. The note, including interest at 10%, matures on September 24, 2020. After 180 days, being from March 23, 2021, the note is convertible at a conversion price which is at 39% discount to the lowest trading price during the previous twenty trading days prior to the date of a conversion notice. The note contained an original issue discount of $3,000.

The majority shareholder agreed to increase authorized shares if needed in order to settle this debt. This note was discounted $43,475 as at March 23, 2021 and the amount of amortization during the period was $1.932.

On November 11, 2020, the Company closed a Securities Purchase Agreement with Geneva Roth Remark Holdings Inc (“GRRH”). In connection therewith, the Company issued GRRH a convertible note payable in the amount of $53,000. The note, including interest at 10%, matures on November 11, 2020. After 180 days, the note is convertible at a conversion price which is at 39% discount to the lowest trading price during the previous twenty trading days prior to the date of a conversion notice. As the conversion date had not become effective as of March 31, 2021 no derivative liability was recorded. The note contained an original issue discount of $3,000. There was no amortization expense recognized during the period.

XML

RELATED PARTY

6 Months Ended

Mar. 31, 2021

Related Party Transactions [Abstract]

RELATED PARTY

NOTE 4- RELATED PARTY

PGRNZ Limited, a management company controlled by the Company’s Chief Executive Officer, and a Company Director, provides management services to the Company for which the Company is charged $75,000(AUD) quarterly, approximately $56,250 (US). During the three months ended March 31, 2021 and 2020, the Company incurred charges to operations of $16,888 (US) and $16,888 (US), respectively, with respect to this arrangement.

As of March 31, 2021 and September 30, 2020, accrued expenses due to PGRNZ and other related parties was $810,116 and $717,075 respectively.

XML

STOCKHOLDERS’ EQUITY

6 Months Ended

Mar. 31, 2021

Equity [Abstract]

STOCKHOLDERS’ EQUITY

NOTE 5 – STOCKHOLDERS’ EQUITY

Other than for Stock based compensation (see Note 2), 1,450,000 new common shares were issued during the six month period ending March 31, 2021 for proceeds totaling $115,214.

The Company has a total of 5,778,366 shares that remain approved, reserved and outstanding and not yet issued by the Transfer Agent at March 31, 2021

XML

COMMITMENTS & CONTINGENCIES

6 Months Ended

Mar. 31, 2021

Commitments and Contingencies Disclosure [Abstract]

COMMITMENTS & CONTINGENCIES

NOTE 6 – COMMITMENTS & CONTINGENCIES

Contingencies

From time to time, we may be involved in routine legal proceedings, as well as demands, claims and threatened litigation that arise in the normal course of our business. The ultimate amount of liability, if any, for any claims of any type (either alone or in the aggregate) may materially and adversely affect our financial condition, results of operations and liquidity. In addition, the ultimate outcome of any litigation is uncertain. Any outcome, whether favorable or unfavorable, may materially and adversely affect us due to legal costs and expenses, diversion of management attention and other factors. We expense legal costs in the period incurred. We cannot assure you that additional contingencies of a legal nature or contingencies having legal aspects will not be asserted against us in the future, and these matters could relate to prior, current or future transactions or events. As of March 31, 2021, there were no pending or threatened litigation against the Company.

XML

SUBSEQUENT EVENTS

6 Months Ended

Mar. 31, 2021

Subsequent Events [Abstract]

SUBSEQUENT EVENTS

NOTE 7 – SUBSEQUENT EVENTS

During the month of April 2021 additional Common shares of 450,000 were approved at a share price of approximately $0.05 and Commons shares of 100,000 were approved for Stock based compensation to a company advisor at $0.50.

XML

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PRESENTATION (Policies)

6 Months Ended

Mar. 31, 2021

Accounting Policies [Abstract]

Principles of Consolidation and Basis of Presentation

Principles of Consolidation and Basis of Presentation — The consolidated financial statements include the accounts of Graphene & Solar Technologies Limited and its subsidiary. All significant intercompany accounts and transactions have been eliminated in consolidation.

The accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the accounting and disclosure rules and regulations of the U.S. Securities and Exchange Commission (“SEC”). A summary of the significant accounting policies applied in the preparation of the accompanying financial statements can be found in the Company’s Annual Report in form 10-K for the year ended September 30, 2020.

Use of Estimates

Use of Estimates - The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Significant estimates include but are not limited to the estimated useful lives of equipment for purposes of depreciation and the valuation of common shares issued for services, equipment and the liquidation of liabilities.

Cash and Cash Equivalents

Cash and Cash Equivalents-Cash and cash equivalents are carried at cost and represent cash on hand, demand deposits placed with banks or other financial institutions and all highly liquid investments with an original maturity of three months or less as of the purchase date of such investments. As of March 31, 2021 and 2020, the Company had $147 and $1,886 in cash, respectively, and no cash equivalents.

Concentrations

Concentrations - As of March 31, 2021, there were no known concentrations other than those identified in Note 3 and Note 4 below.

Derivative Financial Instruments

Derivative Financial Instruments – The Company accounts for freestanding contracts that are settled in a company’s own stock, including common stock warrants, to be designated as an equity instrument or generally as a liability. A contract so designated is carried at fair value on a company’s balance sheet, with any changes in fair value recorded as a gain or loss in a company’s results of operations.

The Company records all derivatives on the balance sheet at fair value, adjusted at the end of each reporting period to reflect any material changes in fair value, with any such changes classified as changes in derivatives valuation in the statement of operations. The calculation of the fair value of derivatives utilizes highly subjective and theoretical assumptions that can materially affect fair values from period to period. The recognition of these derivative amounts does not have any impact on cash flows.

At the date of the conversion of any convertible debt, the pro rata fair value of the related embedded derivative liability is transferred to additional paid-in capital.

There was no derivative activity in fiscal quarter ending March 31, 2020. Therefore, no derivative liabilities were recorded during the quarter ended March 31, 2021.

Stock-Based Compensation

Stock-Based Compensation -ASC 718, “Compensation - Stock Compensation,” prescribes accounting and reporting standards for all share-based payment transactions in which employee and non-employee services are acquired. Transactions include incurring liabilities, or issuing or offering to issue shares, options and other equity instruments such as employee stock ownership plans and stock appreciation rights. Share-based payments to employees and non-employees, including grants of employee stock options, are recognized as compensation expense in the financial statements based on their fair values on the grant date. That expense is recognized over the period during which an employee is required to provide services in exchange for the award, known as the requisite service period (usually the vesting period).

During the quarter ended March 31, 2021, the Company issued 3,688,596 shares of the Company’s common stock to consultants. Since September 30,2020 the Company has issued a total of 6,788,596 shares of the Company’s common stock to consultants. The fair value of the shares, as determined by reference market price of the Company’s common stock on each grant date, during the quarter ended March 31, 2021aggregated $3,422,500.

During the quarter ended March 31, 2019, the Company issued no shares of the Company’s common stock to members of the Board of Directors, employees and consultants.

Total stock-based compensation expense was $3,827,450 and $0 for the quarters ended March 31, 2021 and 2020, respectively.

Foreign Currency Translations

Foreign Currency Translations – The functional currency of the Company’s foreign subsidiary is primarily the respective local currency. Assets and liabilities of the Company’s foreign subsidiary are translated into U.S. Dollars at the year-end exchange rate, and revenues and expenses are translated at average monthly exchange rates. Translation gains and losses are recorded as a component of accumulated other comprehensive income (loss) within stockholders’ equity. All other foreign currency transaction gains and losses are included in other (income) expense, net.

Earnings Per Share

Earnings Per Share - Basic earnings per share have been calculated based upon the weighted-average number of common shares outstanding. Diluted earnings per share were not calculated as such potential shares would be anti-dilutive.

Reclassifications

Reclassifications - Certain amounts previously presented for prior periods have been reclassified to conform to the current presentation. The reclassifications had no effect on net loss, working capital or equity previously reported.

XML

CONVERTIBLE NOTES PAYABLE (Tables)

6 Months Ended

Mar. 31, 2021

Debt Disclosure [Abstract]

Schedule of notes payable

The Company’s indebtedness as of March 31,2021 and September 30, 2020 were as follows:

Description	March 31, 2021		September 30, 2020
Convertible notes	$	202,292	$	168,967
Notes Payable	$	60,000	$	60,000
Other loans		5,781		5,632

XML

Schedule of notes payable (Details) - USD ($)	Mar. 31, 2021	Sep. 30, 2020
Debt Disclosure [Abstract]
Convertible notes	$ 202,292	$ 168,967
Notes Payable	60,000	60,000
Other loans	$ 5,781	$ 5,632